[vc_row][vc_column][vc_single_image image="60018" img_size="full" alignment="center"][vc_column_text]The National Foundation for Cancer Research (NFCR) and CEO Sujuan Ba, Ph.D., congratulate the Global Coalition for Adaptive Research (GCAR) for their continued commitment to expanding options for cancer patients and perseverance in the fight against difficult-to-treat cancers. Recently, GCAR announced its strategic...
[vc_row][vc_column][vc_video link="https://youtu.be/rdaM4fnHLT0" el_width="80" align="center"][vc_column_text] Today is GBM Awareness Day. GBM is one of the deadly cancers that has seen very few significant updates over the last 20 years. The lack of breakthroughs is not because researchers aren't trying - they are - but because there is...
[vc_row][vc_column][vc_single_image image="49165" img_size="full" alignment="center"][vc_column_text]On Wednesday, April 20, 2022, National Foundation for Cancer Research (NFCR) CEO Sujuan Ba and Scientific Board Chairman Web Cavenee joined NBC4 Washington’s Doreen Gentzler to talk about the passing of beloved journalist Wendy Rieger. Rieger passed on Saturday, April 16, 2022, after a battle...
FOR IMMEDIATE RELEASE: November 8, 2018 CONTACT: Global Coalition for Adaptive Research Rachel Rosenstein-Sisson, Executive Assistant E-mail: rrosenstein.sisson@gcaresearch.org / Phone: 617-299-6471 National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 LEXINGTON, MA & ROCKVILLE, MD - Gary Gordon, M.D., Ph.D., has been named...
Medical knowledge of glioblastoma multiforme (GBM), the deadliest form of brain cancer, has grown exponentially, but has not resulted in marked improvements in treatment for patients. Addressing this is GBM AGILE (GBM Adaptive Global Innovative Learning Environment), a global medical and scientific coalition that is...
[vc_row][vc_column][vc_column_text css=""]Glioblastoma multiforme—also known as GBM—is the most lethal form of brain cancer in adults. This devastating brain cancer spreads into other parts of the brain very quickly and is usually not surgically curable. Typically, radiation and chemotherapy are given with the hopes of delaying...
Testing new treatments is key to successfully treating cancer. Unfortunately, the current model for conducting clinical trials — evaluating the effectiveness of therapies on human subjects — is inefficient, expensive and suffers from high failure rates. To overcome these challenges, the practice of adaptive trials is...
Search NFCR
Popular searches
